Medical isotope firm IsoRay reported preliminary 2006 fiscal-year numbers that showed revenues growing sharply, although the firm's net loss grew.
For the year, IsoRay reported sales of $2 million, up 998% compared with the $202,000 booked in the 2005 fiscal year. For the year (end-June 30), the Richland, WI-based company had a consolidated operating loss of $7 million, compared with an operating loss of $4 million a year ago.
IsoRay CEO Roger Girard said that the firm is continuing to make significant progress towards achieving operating breakeven levels within the 2007 calendar year.
By AuntMinnie.com staff writers
September 6, 2006
Related Reading
IsoRay raises $5 million, August 18, 2006
IsoRay begins cesium-131 production testing
IsoRay forecasts record seed orders, June 20, 2006
IsoRay names Hunt as controller, April 19, 2006
IsoRay adds medical advisor, February 1, 2006
Copyright © 2006 AuntMinnie.com
